THRIVENT FINANCIAL FOR LUTHERANS - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
THRIVENT FINANCIAL FOR LUTHERANS ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,283
+10.0%
30,5670.0%0.00%0.0%
Q4 2022$1,166
-99.5%
30,567
+398.9%
0.00%
+200.0%
Q3 2022$240,000
+18.2%
6,1270.0%0.00%
Q1 2022$203,000
-89.9%
6,127
-87.0%
0.00%
-100.0%
Q4 2021$2,005,000
+34.7%
47,139
+137.1%
0.00%
+33.3%
Q1 2021$1,488,000
-54.1%
19,883
-47.0%
0.00%
-62.5%
Q4 2020$3,244,000
+10.1%
37,505
-22.2%
0.01%0.0%
Q3 2020$2,947,000
+44.2%
48,226
-1.9%
0.01%
+33.3%
Q2 2020$2,044,000
+45.2%
49,154
+0.3%
0.01%
+20.0%
Q1 2020$1,408,000
-71.1%
49,023
-27.5%
0.01%
-64.3%
Q4 2019$4,878,000
-42.3%
67,579
+12.0%
0.01%
-46.2%
Q3 2019$8,461,000
-21.4%
60,314
+2.6%
0.03%
-21.2%
Q2 2019$10,761,000
+15.8%
58,772
+0.6%
0.03%
+13.8%
Q1 2019$9,295,000
+67.7%
58,439
+1.0%
0.03%
+45.0%
Q4 2018$5,543,000
+105.3%
57,863
+202.7%
0.02%
+150.0%
Q3 2018$2,700,000
-19.5%
19,118
-10.8%
0.01%
-27.3%
Q2 2018$3,355,000
-2.3%
21,437
+0.5%
0.01%
-8.3%
Q1 2018$3,434,000
-1.0%
21,322
+1.3%
0.01%0.0%
Q4 2017$3,467,00021,0500.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders